Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cytoskeletal and Stem Cell Studies

Executive Summary: Y-27632 dihydrochloride is a small-molecule inhibitor targeting ROCK1 and ROCK2 with high selectivity, exhibiting IC50 values of 140 nM and 300 nM, respectively [ApexBio]. It is cell-permeable and disrupts Rho-mediated stress fiber formation, directly affecting cytoskeletal organization [Ni et al., 2022]. This compound enhances the viability of human pluripotent stem cells and reduces tumor invasion in animal models. Y-27632 is highly soluble in DMSO, ethanol, and water, and is widely used in cell biology, cancer, and regenerative medicine research [Gant61.com]. Its selectivity profile makes it the benchmark tool for Rho/ROCK pathway interrogation across species and cell types.

Biological Rationale

The Rho/ROCK pathway orchestrates cytoskeletal dynamics, cell adhesion, migration, proliferation, and apoptosis. Rho-associated coiled-coil containing protein kinases (ROCK1 and ROCK2) act downstream of RhoA GTPase to phosphorylate key effector proteins, leading to actin stress fiber assembly and myosin light chain activation. Aberrant ROCK signaling contributes to pathological conditions such as cancer metastasis, fibrosis, and neurodevelopmental disorders [Ni et al., 2022]. Selective ROCK inhibition enables researchers to parse the contributions of Rho/ROCK signaling to disease phenotypes and cellular processes. In stem cell biology, the pathway's modulation is critical for survival and maintenance of pluripotency during reprogramming and passaging [BMS345541hydrochloride.com].

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride is a competitive, ATP-site-binding inhibitor of both ROCK1 and ROCK2 kinases. It binds the catalytic domain of these kinases, blocking the phosphorylation of downstream targets such as myosin light chain (MLC), LIM kinase, and cofilin [DMG-PEG2000-Biotin.com]. This inhibition prevents actin stress fiber formation and focal adhesion assembly, resulting in altered cell morphology, decreased contractility, and impaired cytokinesis. The IC50 for ROCK1 inhibition is approximately 140 nM; for ROCK2, the Ki is 300 nM. Y-27632 has over 200-fold selectivity against related kinases such as PKC, PKA, MLCK, and PAK, minimizing off-target effects [ApexBio]. The compound is cell-permeable and rapidly distributes in vitro, exerting effects within minutes of application.

Evidence & Benchmarks

• Y-27632 dihydrochloride enhances survival of human iPSC and ESC cultures by inhibiting dissociation-induced apoptosis (DOI: 10.1016/j.scr.2022.102710).
• It inhibits proliferation of prostatic smooth muscle cells in vitro in a concentration-dependent manner (ApexBio Product Data link).
• In mouse models, Y-27632 suppresses tumor invasion and metastasis by disrupting actin cytoskeleton remodeling (DOI: 10.1016/j.scr.2022.102710).
• Solubility profile: ≥111.2 mg/mL in DMSO, ≥17.57 mg/mL in ethanol, ≥52.9 mg/mL in water (ApexBio Product Data link).
• Y-27632 does not significantly inhibit PKC, cAMP-dependent protein kinase, MLCK, or PAK at concentrations selective for ROCK1/2 (ApexBio Product Data link).
• Pluripotency and karyotypic stability of iPSC lines maintained with Y-27632 supplementation have been confirmed by STR profiling and teratoma assays (DOI: 10.1016/j.scr.2022.102710).

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is broadly used in:

• Stem cell culture: Prevents apoptosis during single-cell dissociation and enhances viability of human and mouse iPSCs/ESCs [Gant61.com].
• Cytoskeletal research: Used to dissect Rho/ROCK-mediated actin dynamics and cell morphology [DMG-PEG2000-Biotin.com].
• Cancer biology: Blocks invasion and metastasis in preclinical tumor models by inhibiting cell motility and matrix degradation [Ribosomal-protein-l3-peptide-202-222-amide.com].
• Cell proliferation assays: Quantifies the impact of ROCK inhibition on cell cycle progression and cytokinesis.

This article extends the protocol guidance and troubleshooting strategies discussed in Y-27632 Dihydrochloride: Precision ROCK Inhibition for Advanced Cell Models by focusing on quantitative evidence and emerging pitfalls in pluripotent stem cell and cancer applications.

Common Pitfalls or Misconceptions

• Y-27632 does not block RhoA activation upstream; it only inhibits ROCK1/2 catalytic activity.
• Long-term continuous use (>7 days) in stem cell cultures may mask differentiation defects or select for abnormal clones.
• Not effective against non-ROCK kinases such as PKC, MLCK, or PAK at standard concentrations.
• Cannot reverse established fibrosis or tumor structures; most effective as a prophylactic or early-stage intervention.
• Solubility may require warming or sonication; precipitation at high concentrations can occur if not properly dissolved.

Workflow Integration & Parameters

For optimal experimental results, Y-27632 dihydrochloride should be reconstituted in DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), or water (≥52.9 mg/mL). Stock solutions should be aliquoted and stored at ≤-20°C to avoid repeated freeze-thaw cycles. For stem cell applications, a final working concentration of 10 μM is commonly used during single-cell passaging or reprogramming steps. Solubility can be improved by warming to 37°C or brief sonication. Solutions should be prepared fresh for each experiment to prevent degradation. The compound is supplied as a solid and should be stored desiccated at 4°C or lower. For functional cell assays, exposure times typically range from 15 minutes (acute cytoskeletal remodeling) to 48 hours (cell survival/proliferation endpoints). Refer to the A3008 kit for batch-specific guidelines and quality controls.

For additional troubleshooting and protocol optimization, see this advanced guide, which complements the present article by focusing on hands-on strategies and error mitigation in complex models.

Conclusion & Outlook

Y-27632 dihydrochloride remains the gold standard for selective, reversible inhibition of ROCK1/2 in cell biology. Its high potency, selectivity, and cell permeability enable precise dissection of Rho/ROCK-dependent pathways in stem cell, cancer, and cytoskeletal research. Ongoing studies continue to expand its utility in regenerative medicine and disease modeling. Careful attention to solubility, dosing, and application context is necessary to avoid pitfalls and maximize experimental reproducibility. For further reference and sourcing, see the official product page.